JOINT FILING AGREEMENT
Exhibit 1
The undersigned hereby agree that the statement on Schedule 13G with respect to the Common Stock, $0.001 par value, of ANGIOTECH PHARMACEUTICALS, INC., is, and any amendments thereto signed by each of the undersigned shall be, filed pursuant to and in accordance with the provisions of Rule 13(d)-1(k) under the Securities Exchange Act of 1934, as amended.
Dated: February 16, 2010
| WEST COAST ASSET MANAGEMENT, INC. | ||
| R. ATTICUS ▇▇▇▇ | ||
| ▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ | ||
| ▇▇▇▇ ▇. ▇▇▇▇▇▇▇ | ||
| By: | /s/ ▇▇▇▇▇ ▇▇▇▇▇▇▇ | |
| Name: | ▇▇▇▇▇ ▇▇▇▇▇▇▇ | |
| Title: | Chief Financial Officer of the Managing Member (for itself and as the Managing Member of the Fund) and Attorney-in-fact for each of the Principals | |